The brain receives and integrates environmental and metabolic information, transforms these signals into adequate neuronal circuit activities, and generates physiological behaviors to promote energy homeostasis. The responsible neuronal circuitries show lifetime plasticity and guaranty metabolic health and survival. However, this highly evolved organization has become challenged nowadays by chronic overload with nutrients and reduced physical activity, which results in an ever-increasing number of obese individuals worldwide. Research within the last two decades has aimed to decipher the responsible molecular and cellular mechanisms for regulation of the hypothalamic melanocortin neurons, which have a key role in the control of food intake and energy metabolism. This review maps the central connections of the melanocortin system and highlights its global position and divergent character in physiological and pathological metabolic events. Moreover, recently uncovered molecular and cellular processes in hypothalamic neurons and glial cells that drive plastic morphological and physiological changes in these cells, and account for regulation of food intake and energy metabolism, are brought into focus. Finally, potential functional interactions between metabolic disorders and psychiatric diseases are discussed. 1 Basically, energy homeostasis is achieved by balancing food intake and energy consumption. As food seeking has always represented an evolutionary pressure, individuals were forced to develop adequate strategies that would guaranty constant energy supply not just when food was plentiful, but also when it was restricted or temporarily unavailable. For this reason, it evolved that energy intake dominates energy expenditure with the consequence that excess energy is stored and used during 'bad times'. Therefore, during evolution, those individuals that developed neuronal circuitries for adequate control of energy metabolism by providing a robust 'pro-feeding' behavioral outcome were successful and survived.
INTRODUCTION
Maintenance of energy homeostasis not only guaranties the survival of an individual organism but also provides reproductive success with the final accomplishment being the continuance of an entire species. 1 Basically, energy homeostasis is achieved by balancing food intake and energy consumption. As food seeking has always represented an evolutionary pressure, individuals were forced to develop adequate strategies that would guaranty constant energy supply not just when food was plentiful, but also when it was restricted or temporarily unavailable. For this reason, it evolved that energy intake dominates energy expenditure with the consequence that excess energy is stored and used during 'bad times'. Therefore, during evolution, those individuals that developed neuronal circuitries for adequate control of energy metabolism by providing a robust 'pro-feeding' behavioral outcome were successful and survived. 2 However, in today's world, access to food no longer reflects an evolutionary pressure, since in general, it is more readily available with little physical effort required. For this reason, the highly evolved regulation of energy metabolism is challenged because it cannot handle the chronic overload of nutrients. This ultimately results in ever-increasing numbers of obese individuals and people suffering from metabolic syndrome worldwide. This eventual clinical manifestation not only implies higher rates of type 2 diabetes and cardiovascular diseases, 3 but also promotes the prevalence of neurological and psychiatric diseases because metabolic disturbances are often found in patients with bipolar disorder, schizophrenia or depression. 4, 5 Thus, research within the last two decades has focused on the understanding of the molecular and cellular mechanisms behind the neuronal control of whole-body energy metabolism.
Most likely, all mammalian species including man receive their energy in forms of food containing carbohydrates, lipids and proteins as energy carriers. After digestion, the metabolic fuels are transported to the target cells, become catabolized and their energy is transformed into adenosine triphosphate (ATP) by mitochondrial oxidative phosphorylation. This generated ATP is necessary for anabolic processes to ensure growth, differentiation and survival. Metabolic fuels, not immediately needed for anabolic processes, are further converted biochemically for long-term storage in the body, such as glycogen in liver and muscle or triglycerides in fat depots. In order to regulate food intake and energy metabolism in a way that fully achieves the energy needs of the whole body, the brain steadily has to control all of these physiological activities.
Therefore, behaviors and physiological processes including arousal, locomotor activity, food seeking, eating, digestion, glucose and lipid metabolism as well as the metabolic rate have to be organized and orchestrated by the brain.
2,4,6-10 Thus, it is not surprising that almost all brain areas are at least secondarily involved in the control of food intake and energy metabolism. In line with this, functional control has evolved in brain circuits that have to engage many integrated body systems. Nevertheless, research within the last 20 years has unraveled and conceptualized that the brain contains so-called first-order neurons in specific areas that are considered to be primarily responsible for the control of food intake and energy metabolism. These brain regions are reciprocally connected and appear to be organized in 1 a hierarchical manner (Figure 1a) . The basic physiological function behind these defined anatomical structures is to steadily receive metabolic-related information and to integrate these signals into neuronal circuit activities that in the end generate behaviors to maintain energy homeostasis. This organization is overseen by the hypothalamic melanocortin system.
The arcuate nucleus (ARC) of the hypothalamus harbors specialized neurons that produce endogenous melanocortins The hypothalamus harbors distinct nuclei involved in the maintenance of energy homeostasis. Lesion of the lateral hypothalamus (LH) resulted in hypophagy whereas lesions of medial hypothalamic nuclei (ARC, arcuate nucleus; DMH, dorsomedial hypothalamus; PVN, paraventricular nucleus; VMH, ventromedial hypothalamus) induced hyperphagy and obesity. Peripheral humoral factors and circulating nutrients control the neuronal activity of hypothalamic neurons. The hypothalamus is connected to the parabrachial, serotonergic raphe and various autonomous brainstem nuclei. Hypothalamic and autonomous brainstem projections to the spinal cord concomitantly control the sympathetic outflow to regulate the metabolic rate. The hypothalamus is connected to the dopaminergic midbrain system to bridge homeostatic and hedonic aspects of food intake. Communication between hypothalamus and amygdala controls food associations. Orchestration of complex behaviors and physiological processes related to the control of food intake and energy expenditure is guarantied by projections between hypothalamus and higher brain regions, such as hippocampus and cortex. GIT, gastrointestinal tract; WAT, white adipose tissue. (b) The hypothalamic ARC harbors primary neurons of the melanocortin system: anorexigenic pro-opiomelanocortin (POMC) neurons and the functional antagonistic, orexigenic neuropeptide Y (NPY)/agouti-related protein (AgRP) neurons (GABA, γ-aminobutyric acid; MC4R, melanocortin type 4 receptor; ME, median eminence; 3 V, third ventricle).
and are primarily responsible for control of food intake and energy metabolism. [11] [12] [13] Pro-opiomelanocortin (POMC)-expressing neurons synthesize and release the anorexigenic α-melanocyte-stimulating hormone, which activates melanocortin receptors mainly to promote satiety and increase energy expenditure. Neuropeptide Y (NPY) and agouti-related protein (AgRP) co-expressing NPY/AgRP neurons release orexigenic NPY that acts upon NPY receptors and orexigenic AgRP, which blocks melanocortin receptors. NPY/AgRP neurons also release γ-aminobutyric acid (GABA), which locally inhibits POMC neurons by direct synaptic innervation in the ARC but also mediates orexigenic effects of NPY/AgRP neurons via GABAergic projections from the ARC to other brain areas. [14] [15] [16] [17] The overall function of NPY/AgRP neurons is to promote food intake and decrease energy expenditure. It is interesting to highlight that NPY/AgRP neurons suppress the effects mediated by POMC neurons at multiple points of action, namely by direct local GABAergic inhibition in the ARC, via AgRP-mediated antagonism at melanocortin receptors and by NPY receptor-mediated signaling that functionally counteracts melanocortin receptor-induced cascades (Figure 1b) . This unidirectional anatomical setup could explain why the overall functional outcome of melanocortin feeding circuits is the promotion of food intake rather than satiety.
1 It is also important to address the idea that POMC and NPY/AgRP neurons show lifelong plasticity, which is dependent upon the metabolic status of the body and is locally driven within the ARC by dynamics in metabolic hormones, circulating nutrients and synaptic input organization. [18] [19] [20] [21] All of these aspects will be addressed here and summarized. We will further highlight that local glial cell populations in the ARC regulate plastic adaptations of the melanocortin system. Moreover, studies unraveling plastic changes of intracellular organelles in POMC and NPY/AgRP neurons that account for the plasticity that is dependent upon the metabolic state will be discussed as well. Finally, we discuss potential functional interactions between metabolic disorders and psychiatric diseases.
THE DIVERGENT CHARACTER OF THE MELANOCORTIN SYSTEM
In times of positive energy status, POMC neurons promote satiety and increase energy expenditure mainly by α-melanocytestimulating hormone-mediated activation of melanocortin type 3 and 4 receptors (MC3/4R). 22, 23 Targeted genetic disruption of MC4R induced a severe obese phenotype in mice, which is related to increased food intake and decreased energy expenditure. 24 Mutations in the Mc4r gene also account for severe, early-onset of obesity in humans. 25 Two recent reports outlined the metabolic importance of the MC4R accessory protein MRAP2, which is sufficient to enhance downstream MC4R signaling in neurons. 26, 27 Loss of function in MRAP2 induced a severe obese phenotype in mice and may also account for obesity in man. 28 MC4R is found throughout the central nervous system, with the highest density in hypothalamic and autonomous regions of the brainstem and spinal cord. 23 However, it is important to mention that MC4R activation induces overall divergent effects with regard to regulation of food intake and energy expenditure. 29 For example, the specific restoration of MC4R signaling in neurons of the paraventricular nucleus and in a sub-population of neurons in the amygdala could only partly prevent obesity by normalization of feeding behavior but not by restoration of energy expenditure in global MC4R-deficient mice. 30 Interestingly, re-expression of MC4R in autonomic neurons normalized energy expenditure and glucose homeostasis in global MC4R-deficient mice. 31 Moreover, pharmacological activation of MC4R inhibited parasympathetic preganglionic neurons in the brainstem but activated sympathetic preganglionic neurons in the spinal cord. 32 The specific deletion of MC4R in cholinergic neurons resulted in elevated levels of insulin, and selective re-expression of MC4R in cholinergic sympathetic preganglionic neurons restored obesityassociated hypertension and impaired glucose homeostasis in MC4R-deficient mice. 32 Like MC4R-deficient mice, POMC-deficient mice also develop a severe obese phenotype, which is related to increased food intake and decreased energy expenditure. 33 Similar to MC4R-deficient mice, the selective local restoration of POMC signaling in a distinct subset of POMC neurons never resulted in a complete restoration of the obese phenotype. 34 This again emphasizes the divergent character of the melanocortin system and indicates a local and cell specific, separate regulation of food intake and energy expenditure by POMC neurons.
However, in contrast to whole-body POMC-deficient animals, mice with a global genetic disruption of NPY and/or AgRP surprisingly showed almost normal food intake and body weight, arguing that genetic compensations during embryonic development may account for the absence of a metabolic phenotype in adulthood. 35, 36 Similarly, early postnatal toxin-induced ablation of NPY/AgRP neurons only modestly affected food intake, suggesting that postnatal network-based compensatory effects occur for NPY/ AgRP neuronal functions as well. 37 In this case, mice with Creinducible human diphtheria toxin receptor (DTR) were crossed with AgRP
Cre mice to generate NPY/AgRP DTR mice, allowing for the specific ablation after DT application. In contrast to neonatal DT injections, the toxin-induced ablation of NPY/AgRP neurons in adult mice resulted in self-imposed starvation because of the lack of drive to eat. 16 However, the administration of GABA receptor agonists after adult ablation abolished this severe phenotype and revealed that GABAergic projections from the ARC NPY/AgRP neurons to the brainstem parabrachial nucleus account for NPY/ AgRP-controlled food intake, because GABA release from NPY/ AgRP neurons suppresses calcitonin gene-related peptide-expressing neurons in the parabrachial nucleus. 38 The latter neurons receive excitatory inputs from the nucleus tractus solitarii and project to the amygdala to form a functionally important circuit for suppressing appetite in response to anorexigenic gut-derived hormones, but also in response to toxin application, presumably to signal visceral malaise. 38, 39 The functional relevance of NPY/ AgRP-mediated GABA release was further supported by transgenic mice with selective knockdown of the vesicular GABA transporter in NPY/AgRP neurons. 40 These animals are leaner than their wild-type littermates. As spontaneous miniature inhibitory postsynaptic currents in POMC cells were reduced under fasting conditions in these mice, it could be suggested that impaired GABA release from NPY/AgRP neurons disinhibits POMC neurons and leads to increased energy expenditure that accounts for the lean phenotype observed in these mice. 40 DREADD (designer receptors exclusively activated by designer drugs) technology and optogenetic studies confirmed the functional antagonism of POMC and NPY/AgRP neurons in feeding control. [41] [42] [43] Moreover, these approaches showed that acute activation of NPY/AgRP neurons not only induces food intake but also facilitated motivation for feeding and intensity in food-seeking behavior. 42, 43 This illustrates that NPY/AgRP neurons also trigger behaviors that were not initially associated with the melanocortin system. Another optogenetic study revealed that AgRP-specific activation of NPY/AgRP neurons acutely inhibits local POMC neurons in the ARC, however, with no consequences on short-term feeding, thus indicating once more that feeding mediated by NPY/AgRP neurons can occur independently of MC4R via several targets. 44 The temporal aspect of NPY, AgRP and GABA signaling was analyzed by DREADD in combination with single, double or triple knockdown of NPY, AgRP-specific vesicular GABA transporter and MC4R. 45 It was concluded from this study that NPY and GABA are responsible for the quick feeding response, while AgRP alone is responsible for a more delayed and chronic feeding response.
HORMONAL AND NUTRIENT-DEPENDENT CONTROL OF POMC AND NPY/AGRP NEURONS
The functional outcome of neuronal activation is predicted by its presynaptic input. Following this concept, POMC and NPY/AgRP neurons not only respond to classic neurotransmitters, such as glutamate and GABA, but also to metabolic hormones including insulin, leptin and ghrelin. 15, 19, 21, 46 Moreover, POMC and NPY/AgRP neuronal activities are further reciprocally regulated by variations in circulating metabolic fuels such as glucose and free fatty acids. 47 These observations are conceptually important because they indicate a physiological feedback loop between the central melanocortin system and the peripheral organs.
The central melanocortin system not only generates metabolic information for regulation of peripheral energy expenditure, glucose homeostasis and lipid metabolism, it also receives humoral metabolic information from peripheral organs that acutely regulate the activity of central melanocortin neurons. The physiological importance of this feedback is illustrated by the pathophysiological consequences of lost responsiveness of melanocortin neurons to anorexigenic metabolic hormones. Insulin and leptin resistance reflect major pathophysiological determinations in the onset of metabolic disorders. For example, insulin and leptin receptors are expressed in POMC and NPY/AgRP neurons 48 but the response of POMC neurons to insulin via ATPsensitive potassium channels occurs only in lean, but not obese mice. 49 Leptin is released from white adipose tissue and activates POMC neurons via both, pre-and postsynaptic mechanisms, whereas it decreases the firing rate of NPY/AgRP neurons. 19 Leptin application depolarizes POMC cells and enhances the expression of Pomc mRNA during fasting. The same is true in leptin-deficient (ob/ob) mice. 50 Experiments with mice lacking both insulin and leptin receptors in POMC neurons, showed that these receptors are required for physiological control of glucose homeostasis and fertility. 51 In contrast, the orexigenic gut-derived hormone ghrelin, which is released during calorie restriction and fasting, triggered neuronal activity of NPY/AgRP neurons but led to downregulation of POMC firing, the latter mainly through presynaptic mechanisms (Figure 2b ). 52 Like any other cell type within the body, neurons also have to adapt their cellular activities in response to available metabolic fuels. In particular, the underlying mechanisms that enable hypothalamic neurons to detect the available energy in the extracellular space and to monitor their own intracellular energy resources by measuring the ratio of adenosine monophosphate (AMP) versus ATP are mainly based on the functional activity of AMP kinase (AMPK). 53 AMPK becomes activated when AMP accumulates and triggers the uptake of glucose and fatty acids to induce catabolic events for ATP generation, while AMPK reduces energy-consuming anabolic processes. 54 Fasting induces hypothalamic activity of AMPK and AMPK clearly shows cell autonomous functions in POMC and NPY/AgRP neurons that specifically highlight their respective differential roles in the regulation of energy homeostasis and nutrient sensing. 47, 55 In line with this, AMPK shows target specific differences in various subpopulations of hypothalamic neurons in the ARC but also in other hypothalamic nuclei, such as the ventromedial hypothalamus and paraventricular nucleus. 1 The main function of POMC and NPY/AgRP neurons predicts that their activities have to correlate with the current metabolic status of the body. The activity of the NPY/AgRP neurons must increase in order to promote hunger and reduce energy expenditure exactly at times when energy resources decline. Thus, it must be guaranteed that NPY/AgRP neurons are adequately 'fueled.' As glucose, which represents the main metabolic fuel for the anorexigenic POMC neurons, is less available during negative energy status, the NPY/AgRP neurons evolved to use free fatty acids as the source of their metabolic energy as these levels increase during fasting. 21, 56 Nutrient-specific activation of POMC and NPY/AgRP neurons occurs in concert with the presence of respective metabolic hormones. For example, the firing of POMC neurons is induced by leptin-mediated opening of nonspecific cation channels, which is supported by janus kinase 2-dependent signal transducer and activator of transcription 3 phosphorylation. 57 Concomitantly, a high activity of malonyl-coenzyme A supports glucose utilization and the generation of ATP to depolarize POMC neurons via activation of ATP-sensitive potassium channels. 57 However, it is still under debate whether these intracellular cascades work separately or in concert with regard to the multiple physiological functions of POMC neurons, such as the promotion of satiety and the regulation of energy expenditure, glucose homeostasis and insulin sensitivity. For example, the selective loss of function of AMPK in POMC cells did not affect leptin sensitivity in POMC neurons, which again favors the above-discussed divergent character of the melanocortin neurons.
With regard to NPY/AgRP neurons, the fasting-induced elevation of hypothalamic ghrelin and free fatty acid levels concomitantly promote intracellular events downstream of ghrelin receptor (growth hormone secretagogue receptor 1a) activation in these neurons. 21 Opposite to the POMC neurons, NPY/AgRP neurons do not utilize glucose and are inhibited by malonyl-coenzyme A. In contrast, growth hormone secretagogue receptor 1a activation inactivates malonyl-coenzyme A and by this disinhibits carnitine palmitoyl transferase 1, which enables the transport of long-chain fatty acids into mitochondria where they are utilized through beta-oxidation. 21 Thus, the reciprocal preference in metabolic fuels between the POMC and NPY/AgRP neurons is expressed through selective intracellular signaling cascades in these functionally opposed neurons. 57 It is still not fully understood how nutrient sensing and substrate oxidation is ultimately linked to intracellular processes that trigger the activity of hypothalamic neurons. However, a molecular switch that may address this functional link in NPY/AgRP neurons involves uncoupling protein (UCP) 2-mediated control of reactive oxygen species (ROS). During mitochondrial respiration, ROS arises and represents a fundamental physiological factor in the hypothalamic control of glucose and lipid metabolism. 21, [57] [58] [59] In POMC neurons, ROS accumulates during oxidative phosphorylation of glucose and promotes the activation of POMC neurons during positive energy status. 58 Chemical and pharmacological suppression of ROS in fed mice as well as fasting-induced declines in ROS diminishes POMC activation. 58 In contrast to POMC neurons, the accumulation of ROS in NPY/AgRP neurons inhibits their neuronal activity in the fed state. 21 However, during fasting, AMPKmediated dis-inhibition of carnitine palmitoyl transferase 1 activity and the induction of beta-oxidation initially lead to a short-lasting boost in ROS levels. This short trigger, concomitant with free fatty acids, leads to transcriptional activation of UCP2. 21 Uncoupling of mitochondrial respiration generally reduces ROS production. In NPY/AgRP neurons, UCP2-dependent reduction of ROS guarantees a continuous carnitine palmitoyl transferase 1-dependent supply of fatty acids for mitochondrial oxidative phosphorylation and ATP generation. This mechanism eventually provides a stable energy source for NPY/AgRP neurons in times of negative energy status (Figure 2a) . 21, 57 This cell autonomous control of NPY/AgRP neuronal activity seems to be supported by presynaptic AMPK activation in glutamatergic boutons that innervate the NPY/AgRP neurons. 60 Presynaptic AMPK drives Ca 2+ -dependent synaptic hysteresis onto the NPY/AgRP neurons, which can be reversed by leptin-induced activation of POMC neurons that generate an opioid-dependent negative feedback to the presynaptic glutamatergic boutons innervating the NPY/ AgRP cells.
METABOLIC STATE-DEPENDENT REGULATION OF HYPOTHALAMIC GLIAL CELLS
Metabolic hormones and nutrients that control the activity of ARC POMC and NPY/AgRP neurons are carried to the central nervous system via the blood stream. Most ARC neurons are behind the blood-brain barrier with the consequence that metabolic hormones and nutrients need a selective transport to pass through. 61 However, other studies support a direct mode of nutrient sensing by subsets of ARC neurons. 62 The macroscopic localization of the ARC and the microscopic ultrastructure indicate that this region has a more direct access to metabolic information arriving via the blood stream as compared with other brain areas.
The ARC lies nearby the third ventricle, which in turn, contains the cerebrospinal fluid. Moreover, the ARC is in close vicinity to the median eminence, a circumventricular organ that is highly vascularized with micro-vessels containing a fenestrated endothelium. 63 The local blood-cerebrospinal fluid barrier, which consists of tanycytes, a specialized hypothalamic type of glial cells, and of endothelial cells of micro-vessels in the median eminence, shows adaptations in their ultrastructure that are dependent upon the metabolic state. 64 Fasting induces fenestration of micro-vessels in the mediobasal part of the ARC, whereas fenestration is restricted to the median eminence during the fed state. To avoid the diffusion of blood-borne molecules into the ventricle, tanycytes line, a tight junction-based impermeable barrier, at the ventral base of the third ventricle in the fed state and elongate this barrier to the lateral-ventral part of the third ventricle during fasting. This process is controlled by tanycytic vascular endothelial growth factor-A expression (Figure 2b) . 65, 66 Tanycytes also express glucose transporter indicating their contribution to central glucose sensing. 67 Moreover, tanycytes, in response to metabolic diets, form a neurogenic niche in the hypothalamus, a mechanism, which is implicated to induce adaptations in energy metabolism in response to certain metabolic signals. 68, 69 The feeding of rodents with a high-fat diet (HFD) is a well known and commonly used model to investigate how chronic overload with nutrients lead to plastic adaptations of the melanocortin system. Rodents on a HFD overeat within the first week but after this initial period the caloric intake equalizes between HFD and normal diet fed animals. 1 However, the mice on the HFD incorporate more fat and become obese. This diet-induced obesity (DIO) is accompanied by severe leptin resistance, which is reversed if the mice are shifted back to a normal diet. 70 Moreover, mice on a HFD develop glucose intolerance after 1 week, whereas insulin levels increase progressively. The cellular events that predict leptin and insulin resistance are not fully understood. However, with regard to HFD, the long-term consequences of a chronic shift in whole-body energy balance, leading to impaired leptin and insulin signaling in melanocortin neurons, are intensively studied in rodent models to understand the pathophysiology behind obesity in humans. Indeed, imbalances of presynaptic and cell autonomous changes in POMC and NPY/AgRP neurons result in plastic adaptations in their neuronal activity and subsequently affect downstream targets in the melanocortin system. After long-term HFD in mice and in humans that suffer from type 2 diabetes, a local angiopathy is observed in the ARC, which is accompanied by astrogliosis and increased numbers of activated microglia, both signifying inflammatory processes. 71, 72 This indicates an impaired ultrastructure of the local micro-vessels and suggests that the finetuned access of POMC and NPY/AgRP neurons to metabolic hormones and nutrients becomes disturbed during obesity.
Tanycytes, astrocytes and microglia are the most relevant glial cell types involved in the hypothalamic control of energy metabolism. Under pathophysiological conditions, glial cells contribute to obesity-associated secondary complications as induced by HFD in rodents or type 2 diabetes in humans. 72, 73 However, glial cells are also implicated to be actively involved in changes under physiological conditions that are dependent upon the metabolic state. 74 Astrocytes generally modulate neuronal development, survival and function. They were initially shown to contribute to plastic adaptations in hypothalamic nuclei responsible for reproduction, osmoregulation and lactation. 75 In the ARC, the reorganization of synaptic inputs onto POMC and NPY/AgRP neurons after leptin or ghrelin application involves astrocytes, as electron micrographs illustrated that the number of synaptic inputs to melanocortin neurons showed an inverse dynamic to astroglial coverage of their cell soma (Figure 2b) . 76 Also, early metabolic events during embryonic development, as assessed by comparative analyses of newborn mice either derived from DIO or lean dams, indicate postnatal alterations in metabolic circuits, which is accompanied by alterations in ARC astroglial numbers and astroglial coverage of melanocortin cells. 76, 77 A recent study actually highlights the importance of early-life metabolic events, as in mice, maternal HFD feeding during lactation predisposes the offspring for obesity and impaired glucose homeostasis. 74 In adult mice and astroglial cultures, leptin induces morphological and functional changes in astrocytes, as indicated by leptin-induced changes in glucose and glutamate transporter as well as apolipoprotein E expression. 77, 78 Microglia become activated in fetal non-human primates after maternal HFD. 79 It was further shown that satiety signals, like leptin promote cytokine and nitric oxide release from activated microglia cells, whereas ghrelin and NPY downregulate the release of proinflammatory cytokines. [80] [81] [82] In rats, early inflammatory responses, such as increased proinflammatory biomarkers and gliosis, were selectively observed within 24 h after HFD exposure in the mediobasal hypothalamus, but not in other brain areas. 72, 83 This occurs even before the onset of obesity as well as before the occurrence of central inflammatory markers. In these local inflammatory events, increased leptin receptors were detected on astrocytes, accompanied by increased astroglial contacts onto the ARC blood vessels. 84 Ongoing research is now deciphering how immediate, low-grade inflammatory events, as occurring shortly after HFD feeding, and chronic hypothalamic inflammation, as induced by long-term exposure to HFD, account for the onset of obesity and the development of obesity-associated impairments in metabolic control, for example, central leptin and insulin resistance.
METABOLIC PLASTICITY OF INTRACELLULAR ORGANELLES IN POMC AND NPY/AGRP NEURONS
Leptin is an adipokine and belongs to the cytokine superfamily. Many authors have argued that leptin resistance is the consequence of impaired activation of anorexigenic POMC neurons by elevated leptin levels during obesity. Some authors claimed that the stress and inflammation-related inhibitor of nuclear factor kappa-B kinase subunit beta/nuclear factor-kb pathway accounts for the onset of leptin resistance. 73 HFD induces endoplasmic reticulum (ER) stress in POMC cells and may lead to activation of Socs3, a repressor of cytokine signaling events. 85 However, the discrepancy between elevated leptin and reduced POMC activation does not account for impaired synaptic transmission in the melanocortin system of DIO mice. 58 Moreover, in rodent DIO models, several neurobiological correlates of the melanocortin system do not show a clear leptin resistance. However, a positive correlation between circulating leptin levels and ROS levels in POMC neurons could be observed in fasted and ob/ob mice but not in DIO mice. The latter showed substantially elevated leptin levels, but no proportional increase in ROS levels in the POMC neurons. 58 ROS are increased during positive energy status and favors the activation of POMC neurons, while fasting induces a decline in ROS that activates the NPY/AgRP and inactivates the POMC neurons. 57 With regard to the ROS, the number of mitochondria is coincidently regulated in POMC neurons. 58 As ROS and mitochondria did not differ between lean fed and DIO mice, the discrepancy between leptin and ROS in DIO mice was not related to UCP2-mediated uncoupling in the mitochondria of POMC neurons. Strikingly, DIO mice showed a correlation between elevated leptin levels and increased numbers of peroxisomes. 58 Peroxisomes also control intracellular ROS levels and their proliferation is under the control of the nuclear transcription factor PPAR-γ (peroxisome proliferator-activated receptor-γ). 86 The Ppar-γ transcript was elevated in the hypothalamus of DIO mice. 58 Pharmacological treatment with PPAR-γ agonists increased POMC peroxisome number, reduced ROS and increased DIO, whereas PPAR-γ blockade leads to a reciprocal reduction in DIO. Finally, blockade of PPAR-γ reversed the firing of both NPY/AgRP and POMC neurons in DIO mice to rates resembling those of lean mice. 58 Hypothalamic peroxisome proliferation is initiated by nutrient overload and peroxisomes originate from the ER. Indeed, ER-stress was shown to contribute to DIO-related leptin resistance. 87, 88 Thus, ER-stress-induced proliferation of peroxisomes leads to the downregulation of ROS and accounts for DIO-related metabolic disturbances such as leptin resistance (Figure 3a) . Mitochondria provide energy needs to the whole cell and are important for regulating the activity of hypothalamic melanocortin neurons in response to dynamics in metabolic hormones and nutrients. 21 In addition to biochemical adaptations regarding mitochondrial respiration, UCP2-mediated uncoupling and ROS scavenging, morphological changes of mitochondria do exist in melanocortin cells and also contribute to metabolic adaptations. 89 Mitochondria fuse with each other or with the ER. This process is controlled by different enzymes and structural proteins, but mainly includes mitofusin (Mfn) 1 and 2. 90 In NPY/AgRP neurons, food deprivation leads to mitochondria fission, whereas HFD leads to mitochondria fusion. 89 Most strikingly, the genetic knockdown of Mfn1 or 2 in NPY/AgRP neurons leads to less weight gain under a HFD when compared with wild-type littermates. This phenotype was related to less accumulation of fat in the peripheral depots. Mfn1 or 2 knockdown induced disruption of mitochondrial fusion and led to an electrical impairment of the NPY/AgRP cells, as indicated by reduced membrane potentials. Equalizing the intracellular ATP levels in NPY/AgRP neurons, which is deficient in Mfn1 or 2 knockdown mice, rescued the electrical impairment. Positive energy status, as it occurs during HFD feeding, induces fusion of mitochondria in the NPY/AgRP neurons to enable sustained, elevated neuronal activity, which is utilized to maximize the storage of excess energy in fat. Impaired fusion was related with decreased activity and resistance to gain fat during HFD feeding. Thus, not only does the re-assembly of synapses onto the NPY/AgRP neurons reflect an adaptive plastic change in response to dynamic changes in nutrients and metabolic hormones, but also intracellular plastic events occur which prove to be indispensable for NPY/AgRP neurons to guaranty the regulation of whole-body energy balance (Figure 3b ). 89 Morphological dynamics in mitochondria also account for proper POMC neuronal function as fewer contacts between ER and mitochondria were observed in these cells under HFD, which was related to HFD-induced downregulation of Mfn2. 91 POMCspecific deletion of Mfn2 induced a severe obese phenotype. Less fusion of mitochondria to the ER induced ER-stress and led to deficient POMC signaling in POMC-specific Mfn2-deficient mice. The impaired processing of POMC during ER-stress was reversed through the use of chaperones (Figure 3c ). 91 Taken together, these three reports delivered fresh insights into cell autonomous plastic changes of intracellular organelles within the melanocortin neurons. This reveals a novel neurobiological principle for plasticity-related adaptations of neuronal function and circuit activity. Local intracellular adaptations of organelle's morphology within distinct neuronal sub-populations, as induced by dynamics in metabolic fuels, accentuate an important cellular event to control physiological processes.
LINKAGE BETWEEN METABOLIC AND PSYCHIATRIC DISORDERS
The issues discussed above raise great enthusiasm for future investigations in the field, with the ultimate goal to better understand the onset of complex behaviors as they relate to metabolic principles. Interestingly, recent research further indicates that melanocortin cells such as the NPY/AgRP neurons also control nonfood-associated physiological behaviors 92, 93 and that their impaired function may potentially be linked to the development of cognitive dysfunctions, as observed in patients suffering from anorexia nervosa. 94 Although genetic, epigenetic as well as environmental parameters as potential pathogens for the onset of psychiatric and neurological disorders have been identified, numerous pathophysiological factors that may account for the onset of most psychiatric disorders still remain unknown. 5, 95, 96 Indeed, numerous descriptive studies and statistical analyses of patient data illustrate bidirectional associations and phenotypic overlaps between metabolic and psychiatric diseases. 5 Patients suffering from serious and chronic mental illness frequently display eating habits and behaviors that will promote obesity and potentially cause metabolic syndrome. 97 This is further accompanied by physical inactivity and a lowering of the basal metabolic rate, as observed in depressive and schizophrenic patients. 98, 99 Moreover, untreated patients with psychiatric disorders show disease-specific impaired metabolic parameters, such as decreased leptin and cholesterol in patients suffering from major depressive disorders and higher levels of these substances in schizophrenic patients. 100 Not only depressive symptoms but also stressful life events predict obesity and metabolic syndrome in humans 101 , and the prenatal exposure to famine increases the risk of schizophrenia in later life. [102] [103] [104] Moreover, rats undergoing cyclic periods of calorie restriction and re-feeding develop compulsive-like behaviors. 105 Anti-psychotic prescriptions, such as clozapine or olanzapine, not only induce imbalances in metabolic parameters and affect body weight, but also induce altered hypothalamic AMPK activity and central MC4R-, GABA-and cannabinoid receptor-driven neurotransmission. [106] [107] [108] According to the bidirectional character of the association between metabolic and psychiatric disorders, metabolic imbalances such as dysfunctions in insulin signaling and glucose homeostasis are implicated as underlying pathophysiological mechanisms for anorexia and bulimia nervosa, 109 and patients with diabetes exhibit an elevated risk for developing depression. 110, 111 So far, therapeutics targeting the melanocortin system and the central nervous system for the treatment of obesity and diabetes aim to reduce food intake by either curbing appetite or suppressing the craving for food. 112 However, many of these agents have been associated with severe psychiatric side effects, highlighting the need for alternative therapeutic strategies, not only for treatment of metabolic disorders, but potentially also for the better handling of psychiatric diseases.
CONCLUDING REMARKS
All of the above-discussed findings and observations support the idea that a better understanding of the underlying central physiological and pathological metabolic events in neurons and glial cells will not only provide better insights into the mechanisms triggering obesity and type 2 diabetes, but also may improve our understandings of the cellular and molecular processes leading to the onset and progression of psychiatric and neurological disorders.
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